Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity

Stem Cells

Volumn 28, Issue 3, 2010, Pages 523-534

  Muramoto, Garrett G ^a   Russell, J Lauren ^a   Safi, Rachid ^a   Salter, Alice B ^a   Himburg, Heather A ^a   Daher, Pamela ^a   Meadows, Sarah K ^a   Doan, Phuong ^a   Storms, Robert W ^a   Chao, Nelson J ^a   McDonnell, Donald P ^a   Chute, John P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adult haematopoietic stem cells; Cord blood; Hematopoietic stem cell transplantation; Retinoic acid; siRNA

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD34 ANTIGEN; DIETHYLAMINOBENZALDEHYDE; ENZYME INHIBITOR; FLT3 LIGAND; RETINOIC ACID; RETINOID; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN FUNCTION; RADIATION PROTECTION; SIGNAL TRANSDUCTION;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELLS, CULTURED; CYTOPROTECTION; ENZYME INHIBITORS; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, CONGENIC; MICE, INBRED C57BL; P-AMINOAZOBENZENE; RADIATION, IONIZING; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TRETINOIN;

MURINAE; MUS;

EID: 77950589175     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.299     Document Type: Article

References (45)

1. Laughlin MJ, Eapen M, Rubinstein P et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004;351:2265-2275.
2. Cornelissen JJ, Lowenberg B. Role of allogeneic stem cell transplantation in current treatment of acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2005:151-155.
3. Alyea EP, Kim HT, Ho V et al. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2006;12:1047-1055.
4. Meijer E, Dekker AW, Lokhorst HM et al. Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation. Transpl Infect Dis 2004;6: 171-178.
5. Barker JN. Umbilical Cord Blood (UCB) Transplantation: An Alternative to the Use of Unrelated Volunteer Donors? Hematology Am Soc Hematol Educ Program2007:55-61.
6. Yang L, Bryder D, Adolfsson J et al. Identification of Lin(-) Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 2005;105:2717-2723.
7. Na Nakorn T, Traver D, Weissman IL et al. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest 2002;109:1579-1585.
8. Plett PA, Frankovitz SM, Orschell-Traycoff CM. In vivo trafficking, cell cycle activity, and engraftment potential of phenotypically defined primitive hematopoietic cells after transplantation into irradiated or nonirradiated recipients. Blood 2002;100:3545-3552.
9. BitMansour A, Burns SM, Traver D et al. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood 2002;100: 4660-4667.
10. Osawa M, Hanada K, Hamada H et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-245.
11. Uchida N, Aguila HL, Fleming WH et al. Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1lo Lin-Sca-1+ hematopoietic stem cells. Blood 1994;83: 3758-3779.
12. Chute JP, Muramoto GG, Whitesides J et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A 2006;103: 11707-11712.
13. Horn PA, Thomasson BM, Wood BL et al. Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primates. Blood 2003; 102:4329-4335.
14. Chute J, Muramoto G, Salter A et al. Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice. Blood 2007;109:2365-2372.
15. Salter A, Meadows S, Muramoto G et al. Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo. Blood 2009;113:2104-2107.
16. Jordan CT, Yamasaki G, Minamoto D. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol 1996;24:1347-1355.
17. Zhang CC, Kaba M, Ge G et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med 2006;12: 240-245.
18. Bonnefoix T, Bonnefoix P, Verdiel P et al. Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit Poisson assumption. J Immunol Methods 1996;194:113-119.
19. Chute J, Saini A, Chute D et al. Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow. Blood 2002;100:4433-4439.
20. Chute J, Muramoto G, Fung J et al. Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID repopulating cells. Blood 2005;105:576-583.
21. Jones RJ, Barber JP, Vala MS et al. Assessment of aldehyde dehydrogenase in viable cells. Blood 1995;85:2742-2746.
22. Storms RW, Trujillo AP, Springer JB et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A 1999;96:9118-9123.
23. Storms RW, Green PD, Safford KM et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood 2005;106:95-102.
24. Hess DA, Meyerrose TE, Wirthlin L et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004;104: 1648-1655.
25. Levi BP, Yilmaz O, Deuster G et al. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood 2009;113:1670-1680.
26. Forsberg E, Prohaska S, Katzman S et al. Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet 2005;1:e28.
27. Ivanova N, Dimos J, Schaniel C et al. A stem cell moleclar signature. Science 2002;298:601-604.
28. Duester G. Genetic dissection of retinoid dehydrogenases. Chem Biol Interact 2001;130-132:469-480.
29. Parrella E, Gianni M, Cecconi V et al. Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the camp and the retinoic acid signaling pathways. J Biol Chem 2004;279:42026-42040.
30. Park D, Chumarakov A, Vuong P et al. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest 1999;103:1399-1408.
31. Walkley CR, Purton LE, Snelling HJ et al. Identification of the molecular requirements for an RAR alpha-mediated cell cycle arrest during granulocytic differentiation. Blood 2004;103:1286-1295.
32. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/ G(2)/M transit and do not reenter G(0). Blood 2000;96:4185-4193.
33. Traycoff CM, Orazi A, Ladd AC et al. Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol 1998;26:53-62.
34. Pearce DJ, Bonnet D. The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells. Exp Hematol 2007;35:1437-1446.
35. Haselbeck RJ, Hoffmann I, Duester G. Distinct functions for Aldh1 and Raldh2 in the control of ligand production for embryonic retinoid signaling pathways. Dev Genet 1999;25:353-364.
36. Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 2002;16:1896-1905.
37. Kastner P, Chan S. Function of RARalpha during the maturation of neutrophils. Oncogene 2001;20:7178-7185.
38. Tsai S, Bartelmez S, Heyman R et al. A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev 1992; 6:2258-2269.
39. Safi R, Muramoto G, Salter A et al. Pharmacological manipulation of the RAR/RXR signaling pathway maintains the repopulating capacity of hematopoietic stem cells in culture. Mol Endocrinol 2009;23: 188-201.
40. Tallman MS, Andersen JW, Schiffer CA et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997;337:1021-1028.
41. Purton LE, Bernstein ID, Collins SJ. All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sca-1(+)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors. Blood 1999;94:483-495.
42. Purton LE, Bernstein ID, Collins SJ. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood 2000;95:470-477.
43. Purton LE, Dworkin S, Olsen GH et al. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med 2006;203:1283-1293.
44. Ginestier C, Hur M, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-567.
45. Huang E, Hynes M, Zhang T et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009;69: 3382-3389.